炎症,免疫和HMG-CoA减少酶抑制剂:他类药物作为抗炎药物?
1Leducq Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Circulation
|June 3, 2004
概括
用于胆固醇的他类药物也可能对抗动脉样硬化的炎症. 研究审查了其抗炎作用的证据,超出了降脂治疗心血管疾病的范围.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化传统上被视为被动脂质沉积,导致针对脂质代谢的疗法.
- 当代的理解强调动脉样硬化是一种积极的炎症过程,涉及免疫系统.
研究的目的:
- 研究抗炎干预措施在动脉样硬化治疗中的潜力.
- 审查除了降脂之外,他类药物的抗炎功能的证据.
主要方法:
- 在体外和体内研究的审查.
- 检查实验模型和间接的人类数据.
- 对3 - 基-3 - 甲基氨酸辅酶A (HMG-CoA) 减少酶抑制剂 (他类药物) 的分析.
主要成果:
- 类药物具有双重功能:调节脂质代谢和潜在调节炎症.
- 有证据表明,通过抗炎作用,他类药物可能会给心血管带来好处.
- 关于他类药物的非降低LDL的类作用的临床相关性存在争议.
结论:
- 类药物是有前途的药物,在动脉样硬化中具有潜在的抗炎作用.
- 需要进一步的临床研究来澄清抗炎疗法的类型和患者选择.
- 了解他类药物的性作用对于优化心血管疾病治疗至关重要.
相关概念视频
Inflammation
46.8K
Overview
46.8K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Inflammatory Response
12.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
897
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73


